0001062993-23-004232.txt : 20230221
0001062993-23-004232.hdr.sgml : 20230221
20230221162424
ACCESSION NUMBER: 0001062993-23-004232
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230221
DATE AS OF CHANGE: 20230221
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Laing Lance G.
CENTRAL INDEX KEY: 0001716041
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38207
FILM NUMBER: 23648555
MAIL ADDRESS:
STREET 1: C/O CELCUITY, 16305 36TH AVENUE N.
STREET 2: #450
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 100
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2023-02-16
0001603454
Celcuity Inc.
CELC
0001716041
Laing Lance G.
16305 36TH AVENUE N.
SUITE 100
MINNEAPOLIS
MN
55446
1
1
1
0
Chief Science Officer
Common Stock
1250000
D
Stock Option (right to buy)
8.4000
2027-05-17
Common Stock
16125
16125
D
Stock Option (right to buy)
5.50
2027-09-19
Common Stock
4110
4110
D
Stock Option (right to buy)
5.50
2028-10-17
Common Stock
1834
1834
D
Stock Option (right to buy)
5.50
2029-08-12
Common Stock
50000
50000
D
Stock Option (right to buy)
5.9000
2030-08-12
Common Stock
20000
20000
D
Stock Option (right to buy)
5.50
2030-12-28
Common Stock
2771
2771
D
Stock Option (right to buy)
5.50
2031-02-02
Common Stock
3215
3215
D
Stock Option (right to buy)
5.50
2031-03-18
Common Stock
2973
2973
D
Stock Option (right to buy)
5.50
2031-04-12
Common Stock
6754
6754
D
Stock Option (right to buy)
5.50
2031-08-11
Common Stock
20000
20000
D
Stock Option (right to buy)
5.50
2031-10-27
Common Stock
1877
1877
D
Stock Option (right to buy)
5.50
2032-05-17
Common Stock
38412
38412
D
Stock Option (right to buy)
11.55
2023-02-16
4
A
0
9156
0
A
2033-02-16
Common Stock
9156
9156
D
Fully vested.
12,500 shares vest on 8/12/20; the remaining 37,500 shares vest 1/36th per month thereafter.
5,000 shares vest on 8/12/21; the remaining 15,000 shares vest 1/36th per month thereafter.
692 shares vest on 12/29/21; the remaining 2,079 shares vest 1/36th per month thereafter.
803 shares vest on 2/2/22; the remaining 2,412 shares vest 1/36th per month thereafter.
743 shares vest on 3/18/22; the remaining 2,230 shares vest 1/36th per month thereafter.
1,689 shares vest on 4/12/22; the remaining 5,065 shares vest 1/36th per month thereafter.
5,000 shares vest on 8/11/22; the remaining 15,000 shares vest 1/36th per month thereafter.
469 shares vest on 10/27/22; the remaining 1,408 shares vest 1/36th per month thereafter.
These shares vest in equal amounts over fourteen (14) months, beginning June 1, 2022.
These shares vest in equal amounts over twelve (12) months, beginning February 16, 2023.
/s/ Eric O. Madson as Attorney-in-Fact for Lance G. Laing pursuant to Power of Attorney previously filed.
2023-02-21